UBS raises target for MetLife stock from USD 105 to USD 110

Published on 10/12/2026 at 12:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Adjusted earnings reached USD 1.57 billion in the second quarter of 2026, up 15 percent year over year. MetLife stock costs EUR 88.03 on October 12, 2026.

Key points in brief

UBS raised its MetLife price target from USD 105 to USD 110 while maintaining a Buy rating on October 6, 2026.
MetLife reported adjusted earnings of USD 1.57 billion in the second quarter of 2026, up 15 percent year over year.
MetLife stock was trading at EUR 88.03 at Lang & Schwarz on October 12, 2026 at 12:05 p.m. CEST.
The company declared a USD 0.5925 fourth-quarter dividend payable on December 8, 2026.

Moderne Glasfassade einer Versicherungszentrale bei Dämmerung mit Skyline im Hintergrund — Fotorealistische Glasfassade einer Firmenzentrale bei Dämmerung passend zu MetLife Inc. mit ISIN US59156R1086, Illustration mit AI erstellt.

MetLife stock (ISIN US59156R1086) was trading at EUR 88.03 at Lang & Schwarz on October 12, 2026 at 12:05 p.m. CEST. On October 6, 2026, UBS analyst Michael Ward raised the price target from USD 105 to USD 110 and maintained a Buy rating, according to Markets Insider. The target change puts valuation expectations above the latest USD 98.33 closing price on the NYSE on October 9, 2026.

Results support the target revision

MetLife reported USD 1.57 billion in adjusted earnings for the second quarter of 2026, up 15 percent from the prior-year quarter. Adjusted earnings per share increased 20 percent to USD 2.43, while net income reached USD 705 million, according to MarketWatch.

The operating mix was also quantified in the August 5, 2026 release: premiums, fees and other revenues increased 7 percent to USD 13.7 billion, while net investment income rose 18 percent to USD 6.7 billion. Adjusted return on equity was 17 percent, at the top of the company target range, giving the UBS target increase a clear earnings backdrop.

Three events set the valuation path

The chronology starts with August 5, 2026, when MetLife reported second-quarter adjusted earnings of USD 1.57 billion and approved a USD 3.0 billion share repurchase authorization, as documented in its SEC filing carried by MarketWatch. On October 5, 2026, TD Cowen raised its target from USD 105 to USD 110 and kept a Buy rating, according to Markets Insider. On October 6, 2026, UBS made the same target move from USD 105 to USD 110 while retaining Buy, marking the latest event in this sequence.

What does the next report test?

MetLife will release third-quarter 2026 results after the market closes on November 4, 2026, and will hold its earnings call on November 5, 2026, according to Business Wire. The key test is whether adjusted earnings can extend the 15 percent second-quarter growth rate while adjusted return on equity remains at 17 percent.

Dividend adds a dated cash return

MetLife declared a fourth-quarter 2026 common stock dividend of USD 0.5925 per share on October 6, 2026. The payment is scheduled for December 8, 2026, to shareholders of record on November 3, 2026, according to Business Wire.

Stock sits below its yearly high

MetLife had a USD 63.3 billion market capitalization and a USD 67.33 to USD 100.93 52-week range on October 9, 2026. Its USD 98.33 NYSE closing price stood below the USD 100.93 high, while the Lang & Schwarz euro quote was EUR 88.03 on October 12, 2026 at 12:05 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of MetLife stock.